Related Experiment Videos
Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses
1Department of Neurology, University of Chicago, Illinois 60637.
Abstract:
We generated Theiler's murine encephalomyelitis virus mutants resistant to several neutralizing monoclonal antibodies (MAbs) having their epitopes near a trypsin cleavage site of VP1. Neutralization and Western blot (immunoblot) studies suggest that two of the MAbs have identical epitopes that partly overlap the epitope of a third MAb. Sequencing of RNA of the mutants localized the epitopes to a site near the carboxyl end of VP1. The limited diversity of nucleotide changes seen in the mutants and the immunodominance of the site suggest that the carboxyl end of VP1 may have an important function.
Insights
Researchers created Theiler's murine encephalomyelitis virus mutants resistant to neutralizing antibodies. Epitope mapping revealed antibody binding sites near a VP1 protein cleavage site, suggesting this region is critical for viral function.
Area of Science:
- Virology
- Immunology
- Structural Biology
Background:
- Theiler's murine encephalomyelitis virus (TMEV) is a picornavirus that causes central nervous system disease in mice.
- Neutralizing monoclonal antibodies (MAbs) are crucial tools for studying viral structure and function.
- Antibody epitopes on viral proteins often map to functionally important regions.
Purpose of the Study:
- To generate TMEV mutants resistant to neutralizing MAbs.
- To identify the specific epitopes targeted by these MAbs.
- To investigate the functional significance of the VP1 protein in TMEV infection.
Main Methods:
- Generation of TMEV mutants resistant to neutralization by specific MAbs.
- Neutralization assays to confirm antibody resistance.
- Western blot (immunoblot) analysis to characterize antibody binding.
- RNA sequencing to identify mutations in the viral genome.
Main Results:
- Several TMEV mutants resistant to neutralizing MAbs were successfully generated.
- Two MAbs recognized identical or overlapping epitopes located near a trypsin cleavage site of the VP1 protein.
- Mutations conferring resistance were localized to the carboxyl end of VP1.
- Limited nucleotide diversity in mutants suggests immunodominance of this region.
Conclusions:
- The carboxyl terminus of the VP1 protein is a key antigenic site for TMEV.
- This region likely plays a critical role in viral function, potentially related to cell entry or uncoating.
- The identified epitopes are important targets for developing antiviral strategies.